THYROZOL

This brand name is authorized in Estonia, France, Germany, Lithuania, Poland, Romania, Singapore, Tunisia.

Active ingredients

The drug THYROZOL contains one active pharmaceutical ingredient (API):

1	Thiamazole UNII 554Z48XN5E - METHIMAZOLE
	Thiamazole inhibits dose-dependently the incorporation of iodine into tyrosine and thereby the neosynthesis of thyroid hormones. This property permits symptomatic therapy of hyperthyroidism regardless of its cause.
	Read more about Thiamazole

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H03BB02	Thiamazole	H Systemic hormonal preparations, excl. Sex hormones and insulins → H03 Thyroid therapy → H03B Antithyroid preparations → H03BB Sulfur-containing imidazole derivatives
Discover more medicines within H03BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	03629922, 06190065, 06190088
EE	Ravimiamet	1114681, 1114692, 1114704, 1114715, 1114726, 1114737, 1332650, 1332694
FR	Base de données publique des médicaments	62754943, 64371687, 69969425
LT	Valstybinė vaistų kontrolės tarnyba	1029976, 1029977, 1029978, 1033965, 1033966, 1033967, 1033968, 1033969, 1033971, 1033972, 1033973
PL	Rejestru Produktów Leczniczych	100214229, 100214235, 100214241
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66143001, W66143002, W66143003, W66143004, W66143005, W66143006, W66143007, W66144001, W66144002, W66144003, W66144004, W66144005, W66144006, W66144007, W66145001, W66145002, W66145003, W66145004, W66145005
SG	Health Sciences Authority	09588P, 09589P
TN	Direction de la Pharmacie et du Médicament	3183102